CIENCIASMEDICASNEWS: Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Schrijver Lieske H et al. Journal of the National Cancer Institute 2022 1

domingo, 30 de enero de 2022

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Schrijver Lieske H et al. Journal of the National Cancer Institute 2022 1

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)